Fenglu Wu

No ORCID on file · 2 papers in corpus
observational 2025
Drug design, development and therapy ·doi:10.2147/dddt.s523076

PURPOSE: To investigate possible differences in cumulative live birth rates (CLBRs) among three progestins medroxyprogesterone acetate (MPA), dydrogesterone (DYG), and Progesterone within the progestin-primed ovarian stimulation (PPOS) prot…

2024
·doi:10.1016/j.apmt.2024.102409